Indian shares set to open flat as US election results trickle in
Nov 6 (Reuters) -Indian shares are set to open flat on Wednesday, with caution likely to prevail as U.S. presidential election results trickle in.
The Gift Nifty futures GIFc1 were trading at 24,268, as of 07:48 a.m. IST, indicating that the benchmark Nifty 50 .NSEI will open near Tuesday's close of 24,213.3.
Other Asian markets traded lower, with the MSCI Asia ex-Japan index .MIAPJ0000PUS shedding 0.4%, as early results from the U.S. presidential election suggested the race remained too close to call.
Republican Donald Trump won eight states while Democrat Kamala Harris captured three states and Washington, D.C., Edison Research projected, but critical battleground states were unlikely to be called for hours or even days.
A Trump win could lead to lower corporate tax rates in the United States, and is expected to boost spending and benefit several equity sectors in India, according to analysts.
A Harris victory, meanwhile, is seen as a sign of policy continuity, a neutral-to-mildly-positive outcome for Indian stocks, they said.
"Clarity on the outcome of U.S. election will influence markets trajectory in this session," said Deepak Jasani, head of retail research, HDFC Securities.
Indian shares recouped losses to log gains on Tuesday, led by banks, as investors sought safety in segments with cheaper valuations.
The market's recovery in the previous session was driven by short-covering ahead of the U.S. results, but caution persists amid weak earnings and lackluster quarterly results.
Foreign institutional investors sold domestic equities for the 27th consecutive session, offloading stocks worth 25.69 billion Indian rupees, on a net basis.
The benchmark Nifty is about 8% below the all-time high hit on Sept. 27, weighed by record monthly foreign outflows in October as investors directed funds to China from India on Beijing's stimulus measures and cheaper valuations.
The moderation in corporate earnings growth for the September quarter has also weighed on the markets.
STOCKS TO WATCH
** Drugmaker Dr Reddy's Laboratories REDY.NS misses September-quarter profit view on weak U.S. demand
** Mankind Pharma MNKI.NS tops second-quarter profit view on higher demand for chronic drugs
** Titan TITN.NS sees drop in second-quarter profit as gold import tax cut drives inventory losses
** Initial public offering of Swiggy SWIG.NS will open for subscription from Wednesday until Nov. 8, and the stock is expected to list on domestic bourses on Nov. 13
Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sherry Jacob-Phillips
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
